By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Bio-Path Holdings, Inc. 

2626 South Loop
Suite 180
Houston  Texas  77054  U.S.A.
Phone: n/a Fax: n/a



Company News
Bio-Path Holdings, Inc. (BPTH) To Present At The 17th Annual Rodman & Renshaw Global Investment Conference 9/2/2015 10:50:11 AM
Bio-Path Holdings, Inc. (BPTH) Reports Second Quarter 2015 Operational And Financial Results 8/11/2015 11:24:02 AM
Bio-Path Holdings, Inc. (BPTH) Announces "At-the-Market" Offering With Cantor Fitzgerald 6/26/2015 4:18:33 PM
Bio-Path Holdings, Inc. (BPTH) Reports First Quarter 2015 Operational And Financial Results 5/13/2015 10:54:03 AM
Bio-Path Holdings, Inc. (BPTH) Appoints Tara Sadeghi As Director Of Clinical Operations 4/30/2015 12:53:32 PM
Bio-Path Holdings, Inc. (BPTH) Granted Orphan Drug Designation For Liposomal Grb-2 In Acute Myeloid Leukemia 4/28/2015 10:15:49 AM
Bio-Path Holdings, Inc. (BPTH)’ Drug Delivery Technology To Be Featured In A Presentation At IBC Life Sciences17th Annual TIDES Oligonucleotide And Peptide Therapeutics Conference 4/22/2015 8:42:12 AM
Bio-Path Holdings, Inc. (BPTH) Reports Fiscal Year 2014 Operational And Financial Results 3/17/2015 11:59:07 AM
Bio-Path Holdings, Inc. (BPTH) Starts Phase II Study With Liposomal Grb-2 In AML Patients 2/9/2015 10:34:37 AM
Bio-Path Holdings, Inc. (BPTH)’ Liposomal Grb-2 Featured In Peer-Reviewed Journal “Expert Opinion On Drug Delivery” 1/7/2015 11:04:03 AM